Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reindl

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativityC Gneiss, M Reindl, A Lutterotti, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 25, 2000
Expression of Fas and Fas ligand after experimental traumatic brain injury in the ratR Beer, G Franz, M Schöpf, et al.
Nutrition and Cancer|March 22, 2017
Enterolactone Induces G<sub>1</sub>-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent KinasesShireen Chikara, Kaitlin Lindsey, Harsharan Dhillon, et al.
Brain : a Journal of Neurology|November 5, 1999
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative studyM Reindl, C Linington, U Brehm, et al.
Tissue Antigens|March 8, 2003
Mutations in the gene for toll-like receptor 4 and multiple sclerosisM Reindl, A Lutterotti, J Ingram, et al.
Neurology|June 14, 2000
A comparative study of the relative bioavailability of different interferon beta preparationsF Deisenhammer, I Mayringer, J Harvey, et al.
IEEE Transactions on Bio-Medical Engineering|October 15, 2014
RFID Technology for Continuous Monitoring of Physiological Signals in Small AnimalsTobias Volk, Stefan Gorbey, Mayukh Bhattacharyya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MSV Tomassini, L De Giglio, M Reindl, et al.
Neurology|August 30, 2008
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adultsH Wang, K L Munger, M Reindl, et al.
Tissue Antigens|December 4, 2003
Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosisR Ehling, Ch Gassner, A Lutterotti, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativityC Gneiss, M Reindl, A Lutterotti, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 25, 2000
Expression of Fas and Fas ligand after experimental traumatic brain injury in the ratR Beer, G Franz, M Schöpf, et al.
Nutrition and Cancer|March 22, 2017
Enterolactone Induces G<sub>1</sub>-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent KinasesShireen Chikara, Kaitlin Lindsey, Harsharan Dhillon, et al.
Brain : a Journal of Neurology|November 5, 1999
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative studyM Reindl, C Linington, U Brehm, et al.
Tissue Antigens|March 8, 2003
Mutations in the gene for toll-like receptor 4 and multiple sclerosisM Reindl, A Lutterotti, J Ingram, et al.
Neurology|June 14, 2000
A comparative study of the relative bioavailability of different interferon beta preparationsF Deisenhammer, I Mayringer, J Harvey, et al.
IEEE Transactions on Bio-Medical Engineering|October 15, 2014
RFID Technology for Continuous Monitoring of Physiological Signals in Small AnimalsTobias Volk, Stefan Gorbey, Mayukh Bhattacharyya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MSV Tomassini, L De Giglio, M Reindl, et al.
Neurology|August 30, 2008
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adultsH Wang, K L Munger, M Reindl, et al.
Tissue Antigens|December 4, 2003
Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosisR Ehling, Ch Gassner, A Lutterotti, et al.
Pageof 13